BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Annageldiyev C, Gowda K, Patel T, Bhattacharya P, Tan SF, Iyer S, Desai D, Dovat S, Feith DJ, Loughran TP Jr, Amin S, Claxton D, Sharma A. The novel Isatin analog KS99 targets stemness markers in acute myeloid leukemia. Haematologica 2020;105:687-96. [PMID: 31123028 DOI: 10.3324/haematol.2018.212886] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Khokhlatchev AV, Sharma A, Deering TG, Shaw JJP, Costa‐pinheiro P, Golla U, Annageldiyev C, Cabot MC, Conaway MR, Tan S, Ung J, Feith DJ, Loughran TP, Claxton DF, Fox TE, Kester M. Ceramide nanoliposomes augment the efficacy of venetoclax and cytarabine in models of acute myeloid leukemia. The FASEB Journal 2022;36. [DOI: 10.1096/fj.202200765r] [Reference Citation Analysis]
2 Verma H, Narendra G, Raju B, Kumar M, Jain SK, Tung GK, Singh PK, Silakari O. 3D-QSAR and scaffold hopping based designing of benzo[d]ox-azol-2(3H)-one and 2-oxazolo[4,5-b]pyridin-2(3H)-one derivatives as selective aldehyde dehydrogenase 1A1 inhibitors: Synthesis and biological evaluation. Arch Pharm (Weinheim) 2022;:e2200108. [PMID: 35618489 DOI: 10.1002/ardp.202200108] [Reference Citation Analysis]
3 Ung J, Tan S, Fox TE, Shaw JJ, Vass LR, Costa-pinheiro P, Garrett-bakelman FE, Keng MK, Sharma A, Claxton DF, Levine RL, Tallman MS, Cabot MC, Kester M, Feith DJ, Loughran TP. Harnessing the power of sphingolipids: Prospects for acute myeloid Leukemia. Blood Reviews 2022. [DOI: 10.1016/j.blre.2022.100950] [Reference Citation Analysis]
4 Golla U, Ehudin MA, Annageldiyev C, Zeng Z, Bastihalli Tukaramrao D, Tarren A, Date AA, Elcheva I, Berg A, Amin S, Loughran TP Jr, Kester M, Desai D, Dovat S, Claxton D, Sharma A. DJ4 Targets the Rho-Associated Protein Kinase Pathway and Attenuates Disease Progression in Preclinical Murine Models of Acute Myeloid Leukemia. Cancers (Basel) 2021;13:4889. [PMID: 34638385 DOI: 10.3390/cancers13194889] [Reference Citation Analysis]
5 Guo W, Wang H, Chen P, Shen X, Zhang B, Liu J, Peng H, Xiao X. Identification and Characterization of Multiple Myeloma Stem Cell-Like Cells. Cancers (Basel) 2021;13:3523. [PMID: 34298738 DOI: 10.3390/cancers13143523] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
6 Annageldiyev C, Tan SF, Thakur S, Dhanyamraju PK, Ramisetti SR, Bhadauria P, Schick J, Zeng Z, Sharma V, Dunton W, Dovat S, Desai D, Zheng H, Feith DJ, Loughran TP Jr, Amin S, Sharma AK, Claxton D, Sharma A. The PI3K/AKT Pathway Inhibitor ISC-4 Induces Apoptosis and Inhibits Growth of Leukemia in Preclinical Models of Acute Myeloid Leukemia. Front Oncol 2020;10:393. [PMID: 32296637 DOI: 10.3389/fonc.2020.00393] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
7 Dinavahi SS, Gowda R, Bazewicz CG, Battu MB, Lin JM, Chitren RJ, Pandey MK, Amin S, Robertson GP, Gowda K. Design, synthesis characterization and biological evaluation of novel multi-isoform ALDH inhibitors as potential anticancer agents. Eur J Med Chem 2020;187:111962. [PMID: 31887569 DOI: 10.1016/j.ejmech.2019.111962] [Cited by in Crossref: 7] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]